|
SKYE Skye Bioscience Inc 1516551 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-10,786,594.00 |
| Balance Sheet |
|
Current Assets
|
$10,958,887.00 |
|
Assets
|
$11,033,795.00 |
|
Current Liabilities
|
$11,531,102.00 |
|
Liabilities
|
$11,531,102.00 |
|
Equity
|
$-497,307.00 |
|
Shares Out
|
35143722.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-15,679,591.00 |
|
Investing Cash Flow
|
$18,037,989.00 |
| Market Analysis |
Market Cap
|
$9,840,242.16 |
|
Price
|
$1.77 |
|
BVPS
|
0.26 |
|
PB
|
1.08 |
|
EPS
|
-0.27 |
|
FCF
|
$-15,679,591.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:48 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-0.36 |
|
|
2026-05-11 |
-0.32 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.44 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.32 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SKYE documents filed with the SEC.
SKYE Filings
Clear
